Ignite Creation Date:
2024-05-06 @ 3:05 AM
Last Modification Date:
2024-10-26 @ 11:28 AM
Study NCT ID:
NCT02206295
Status:
COMPLETED
Last Update Posted:
2014-08-01
First Post:
2014-07-30
Brief Title:
Study in Healthy Male Subjects to Demonstrate Bioequivalence of 1600 μg Selexipag Administered as Eight Tablets of 200 μg or as Single Tablet of 1600 μg
Sponsor:
Organization:
Actelion